Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease

E-ISSN： 1875-533x|22|27|3169-3184

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.27, 2015-01, pp. : 3169-3184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4958-4968

Bentham Science Publishers

Access to resources Recommend Favorite

New therapeutic patents for Alzheimer’s disease

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1751-1757

Informa Healthcare

Access to resources Recommend Favorite

Tau Protein Phosphorylation as a Therapeutic Target in Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid &bgr; -Protein Assembly as a Therapeutic Target of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 14, Iss. 30, 2008-10 ,pp. : 3231-3246

Bentham Science Publishers

Access to resources Recommend Favorite